Skip to content
SentinelMarket desk
Switch to dark mode

알리코제약

260660KOSDAQView the 제약 sectorTheme Bio & healthcare

2,160KRWMarket close of 10/20 (Tue)

Down -1.14%-25KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)2,130KRWDown -1.39%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
2,150
High
2,200
Low
2,130
Day range
Day range low 2,130 high 2,200, open 2,150, close 2,160, previous close 2,185
Volume
1×10K shares
21.93 million KRW 0.33× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 2,115 to 5,050 won, 2% up from the low

2% of the way up from the lowest close in 1 year (252 sessions) · -57.2% from the high

Usual range

Nothing unusual in the 3 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsnot verifiedOutside financial data coverage, so not verified
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

  • Daily move-1.14%usual range
  • Trading value0.3×usual range
  • Data date10/20 (Tue)Market close
See the full check report

Same sector · 제약

Down -1.68%

· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
셀트리온Close over the last 20 sessions +11.4%Down -0.40%139.2B KRW
삼성바이오로직스Close over the last 20 sessions -1.3%Down -2.52%129.9B KRW
삼익제약Close over the last 20 sessions -20.4%Up +2.77%76.0B KRW
녹십자엠에스Close over the last 20 sessions +30.5%Up +6.67%55.6B KRW
유한양행Close over the last 20 sessions +11.5%Down -1.37%41.6B KRW

Schedule

  • Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.